IRADIMED CORP
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $83.8 | $73.2 | $65.6 | $53.3 | $41.8 |
| Operating income | $26.1 | $22.0 | $20.0 | $15.6 | $9.8 |
| Net income | $22.5 | $19.2 | $17.2 | $12.8 | $9.3 |
| Cash Flow Statement | |||||
| Free cash flow | $17.2 | $17.6 | $6.0 | $9.2 | $10.8 |
| Dividends | $15.0 | $13.7 | $13.2 | $12.6 | — |
Shares outstanding 12.8M · Free float 64.9%
Annual filing data through FY ended December 31, 2025; float as of August 25, 2026.